A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial)

A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial)

Background: Complex regional pain syndrome (CRPS) is a rare, severe post-traumatic pain condition affecting distal limbs. Patients who do not spontaneously improve in 12 months are classed as having ‘long-standing CRPS’ and often cannot be effectively treated, leading to a poor prognosis. CRPS is as...

Full description

Bibliographic Details
Main Authors: Andreas Goebel, Jatinder Bisla, Roy Carganillo, Claire Cole, Bernhard Frank, Rima Gupta, Mairi James, Joanna Kelly, Candy McCabe, Holly Milligan, Caroline Murphy, Nick Padfield, Ceri Phillips, Helen Poole, Mark Saunders, Mick Serpell, Nick Shenker, Karim Shoukrey, Lynne Wyatt, Gareth Ambler
Format: Article
Language:English
Published: NIHR Journals Library 2017-11-01
Series:Efficacy and Mechanism Evaluation
Subjects:
randomised controlled trial
intravenous immunoglobulin
complex regional pain syndrome
Online Access:https://doi.org/10.3310/eme04050

Internet

https://doi.org/10.3310/eme04050

Similar Items